In its seventh year, the Association of Community Cancer Centers (ACCC) Innovator Awards honor Cancer Program Members* for their pioneering achievements in oncology. Innovations should advance the goals of improving access, quality, and value in cancer care delivery.
In partnership with the Institute for Clinical Immuno-Oncology (ICLIO), ACCC will grant an Innovator Award to a program(s) that demonstrates innovation in the delivery of immunotherapies. Winners will be selected through a peer review process.
Criteria for Submissions:
- Does your innovation present a new or improved approach to an issue often seen in treating patients with immunotherapy?
- Does it have the potential to create positive change in the delivery of immunotherapy?
- Is it replicable? Can it be adapted or integrated into practice at other community-based cancer programs?
- Does it advance patients’ access to immunotherapies?
- Does it improve care coordination for patients and providers, including interdisciplinary team members?
- Will it be cost effective to implement? Result in cost saving or generate measurable ROI?
Winners will present their innovations at the ACCC 34th National Oncology Conference, October 18–20, 2017, in Nashville, TN, and will be featured in our journal, Oncology Issues. Winners receive regional and national exposure as their innovations are shared with oncology care providers, the broader healthcare community, and national press outlets.
The deadline for submissions is now closed.
2017 ICLIO Innovator Award Recipient
The Association of Community Cancer Centers (ACCC) and the Institute for Clinical Immuno-Oncology (ICLIO) are proud to announce the 2017 ICLIO Innovator Award recipient, Oncology Specialists, SC. This forward-thinking ACCC Cancer Program Member has created innovative strategies for the effective delivery of immunotherapy in the community setting.
Turning on the Light Switch: A Model Immunotherapy Program at an Oncology Practice
The nursing team at Oncology Specialists, SC, initiated a program that aimed to provide consistent, optimal care for patients receiving immunotherapy. Components include patient and staff education materials, peer-to-peer training, policy and procedure guidelines, toxicity assessment tools, and EHR documentation templates. The result is the creation of tools and procedures that standardized and improved care of immunotherapy patients.
Oncology Specialists, SC, along with the eight ACCC Innovator Award recipients, will present their creative, replicable programs at the ACCC 34th National Oncology Conference, October 18–20, 2017, in Nashville, TN. Winners will be featured in the ACCC journal, Oncology Issues, and receive regional and national exposure as their innovations are shared with oncology care providers, the broader healthcare community, and national press outlets.
The submission process for the 2018 ACCC Innovator Awards will open in January, 2018.
2016 ICLIO Innovator Awards
The Institute for Clinical Immuno-Oncology (ICLIO) selected Sanford Cancer Center in Sioux Falls, SD as the recipient of the 2016 ICLIO Innovator Award for its process improvement initiative enhancing patient treatment options, to include immunotherapy in the community setting. Read an interview with Steven Powell, MD, Sanford Cancer Center to learn how Sanford increases access to immunotherapy clinical trials through weekly tumor-specific video conferences and multidisciplinary molecular tumor boards.
Watch the video, for more details on their winning submission, Expanding Access to Immunotherapy in the Community Setting.